|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, the Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
2 Division of Hematology and Oncology
Correspondence to:
Correspondence to:
Dr Shahid Ahmed, Division of Hematology-Oncology, Department of Medicine, Long Island Jewish Medical Center, 27005, 76th Ave, New Hyde Park, NY, 11040, USA;
shahidahmed00{at}yahoo.com
Pulmonary complications account for significant morbidity and mortality in patients with sickle cell disease. Clinical lung involvement manifests in two major forms: the acute chest syndrome and sickle cell chronic lung disease. Acute chest syndrome is characterised by fever, chest pain, and appearance of a new infiltrate on chest radiograph. Sickle cell chronic lung disease, on the other hand, manifests as radiographic interstitial abnormalities, impaired pulmonary function, and, in its most severe form, by the evidence of pulmonary hypertension. Progress has been made in understanding the pathophysiology and management of these complications. In this review the current knowledge of the mechanism, diagnosis, and treatment of pulmonary complications of sickle cell disease are discussed.
Keywords: sickle cell disease; pulmonary complications; acute chest syndrome
Abbreviations: ACS, acute chest syndrome; MACSS, multicentre acute chest syndrome study; NO, nitric oxide; NYHA, New York Heart Association; SCCLD, sickle cell chronic lung disease; SCD, sickle cell disease; VCAM-1, vascular cell adhesion molecule-1
This article has been cited by other articles:
![]() |
D S KUMAR, R P YADAVALI, L A CONCEPCION, and H ANIQ Acute chest pain in a young woman with a chronic illness Br. J. Radiol., March 1, 2008; 81(963): 261 - 263. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |